TopNewsOn
Health

Dual-action bacterial cancer therapy shrinks aggressive breast tumors in mouse models

Medical Xpress·November 16, 2026

Tumors that resist immune attack, recur and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents. Addressing this, a research team from the Republic of Korea—led by professor John Hwa Lee from the Laboratory of Veterinary Public Health, College of Veterinary Medicine, Jeonbuk National University—developed an engineered strain of Salmonella Typhimurium carrying two anticancer components.

Read the full story at Medical Xpress →